Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Transplant Proc ; 38(1): 282-3, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16504726

RESUMEN

BACKGROUND: Islet cell transplantation is a promising method to restore insulin independence to patients with type 1 diabetes mellitus. A main problem in clinical islet transplantation is the fact that only a small percentage of allogeneic islet-transplanted type 1 diabetic patients can completely omit insulin injections after transplantation. One reason for the impaired survival of islet grafts is aberration of the function of islets due to toxic agents, including oxygen radicals and nitric oxide, which arise during warm or cold ischemic time. Therefore, in clinical islet transplantation, islets have been preserved with a mixture of antioxidants to reduce free radical-mediated damage of transplanted beta cells. Our aim was to examine hepatic tissue after metabolic normalization following intraportal islet transplantation after application of sulforaphane. MATERIALS AND METHODS: Islets were isolated from pancreata of WAG rats. Sulforaphane (24 mg/kg) was administered 24 hours before isolated islets were transplanted into the liver through the portal vein (1200 +/- 100 per rat). At 9 months after transplantation the animals were killed and liver tissue removed for morphological examination. RESULTS: This report indicated that the intrahepatic portal vein site was indeed an excellent locus for implantation of free pancreatic islets. The islet grafts developed rich vascularization derived from both venous and arterial sources. The islet cells maintained their structural and functional integrity after implantation. CONCLUSION: Our results showed that sulforaphane improved islet function in vivo, indicating that combination of a free radical scavenger and an antioxidant (sulforaphane) may be used to increase the effectiveness of islet transplantation.


Asunto(s)
Anticarcinógenos/uso terapéutico , Diabetes Mellitus Experimental/cirugía , Trasplante de Islotes Pancreáticos/métodos , Tiocianatos/uso terapéutico , Animales , Modelos Animales de Enfermedad , Glucagón/análisis , Inmunohistoquímica , Insulina/análisis , Islotes Pancreáticos/citología , Isotiocianatos , Hígado/citología , Masculino , Vena Porta/cirugía , Ratas , Ratas Endogámicas , Sulfóxidos
2.
Biotech Histochem ; 84(1): 17-23, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19115117

RESUMEN

The ability of protoporphyrin IX (PP IX) to enter neoplastic cells is used for diagnosis and photodynamic therapy. We present here the effects of PP IX and three amino acid derivatives on MCF-7 cell viability. The fluorescence of each substance was examined using confocal microscopy. Our results show that diarginine diprotoporphyrinate (PP(Arg)2) has satisfactory fluorescence to evaluate the rate of accumulation within cells. We have determined the times at which the accumulation begins and reaches a plateau, as well as cellular localization of PP(Arg)2 in MCF-7 cells.


Asunto(s)
Neoplasias de la Mama/patología , Protoporfirinas/farmacocinética , Aminoácidos Diaminos , Arginina , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Femenino , Histocitoquímica/métodos , Humanos , Microscopía Fluorescente
3.
Arch Toxicol ; 81(3): 183-200, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16953391

RESUMEN

Polycyclic aromatic hydrocarbons (PAHs) are environmental pollutants. Some compounds belonging to this group are considered carcinogenic to people. In order to yield carcinogenic properties, these compounds must be metabolically transformed by enzymes of cytochrome P450 family to oxy-derivatives. In this study, the ability of the following six PAHs: anthracene (Ant), benz(a)anthracene (BA), naphthacene (Nap), benzo(a)pyrene (BaP), dibenz(a,c)anthracene (DB(a,c)A) and dibenz(a,h)anthracene (DB(a,h)A) to induce enzymes of cytochrome P450 (CYP450), in particular CYP1A1 and CYP1A2 in Mcf7 and HepG2 cells was studied. The induction of CYP1A enzymes was assessed at the level of enzymatic protein and enzymatic activity. The change in CYP1A1 and CYP1A2 protein level was assessed by means of confocal microscopy. The ethoxyresorufin-O-deethylase (EROD) and methoxyresorufin-O-deethylase (MROD) assays were applied to determine the CYP1A1 and CYP1A2 activity. The Induction Equivalency Factors (IEFs) were also determined. According to EROD and MROD assay and calculated IEFs the following order of the inducing potency was determined in HepG2 cells: DB(a,h)A > BaP > DB(a,c)A approximately BA > Nap > Ant, and in Mcf7 cells: DB(a,h)A > DB(a,c)A > BaP > Nap > BA > Ant. The assessment of the protein levels revealed that DB(a,h)A was also the strongest inducer of protein level, however the correlation between enzymatic activity and protein level induction by other PAHs was not always evident. The EROD and MROD activities were higher in Mcf7 than in HepG2 cells, however the CYP1A2 protein level was shown to be higher in HepG2 cells. The results obtained indicate possible catalytic enzymatic activity alterations induced by PAHs.


Asunto(s)
Citocromo P-450 CYP1A1/biosíntesis , Citocromo P-450 CYP1A2/biosíntesis , Hidrocarburos Policíclicos Aromáticos/farmacología , Western Blotting , Línea Celular Tumoral , Citocromo P-450 CYP1A1/análisis , Citocromo P-450 CYP1A2/análisis , Relación Dosis-Respuesta a Droga , Inducción Enzimática/efectos de los fármacos , Humanos , Microscopía Confocal , Relación Estructura-Actividad Cuantitativa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA